Delcath Systems Inc

Searching for Delcath Systems Inc info? Then you have come to exactly the right place. At thebigfreezefestival.com.au we collected all data about Delcath Systems Inc: corporate office address, support phones, working hours, customer complaints, etc.


Delcath Systems Inc.

    https://delcath.com/
    Our Solution: We are investigating a percutaneous targeted, whole-organ therapy that delivers high-dose chemotherapy directly to the liver with subsequent filtration of the …

Delcath Systems - Wikipedia

    https://en.wikipedia.org/wiki/Delcath_Systems

    Delcath Systems, Inc. (DCTH) - Yahoo Finance

      https://finance.yahoo.com/quote/DCTH
      Delcath Systems, Inc. PETS: What does Argus have to say about PETS? PETMED EXPRESS INC has an Investment Rating of HOLD; a target price of $21.000000; an …

    Delcath Systems

      http://delcathsystems.com/
      In the US, our investigational product is called HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system), while in Europe, our commercial product is called …

    Delcath Systems | LinkedIn

      https://www.linkedin.com/company/delcath-systems-inc
      Delcath Systems, Inc. is an interventional oncology company focused on the treatment of metastatic liver …

    Delcath Systems Announces New Drug Application …

      https://finance.yahoo.com/news/delcath-systems-announces-drug-application-134900349.html
      NEW YORK, Feb. 14, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of …

    Delcath Systems Announces New Drug Application …

      https://www.biospace.com/article/releases/delcath-systems-announces-new-drug-application-resubmission-for-hepzato-kit/
      Delcath Systems Announces New Drug Application Resubmission for HEPZATO Kit | BioSpace Skip to main content Login | Employer Login News Jobs …

    DCTH Stock Price | Delcath Systems Inc. Stock Quote …

      https://www.marketwatch.com/investing/stock/dcth
      Delcath Systems Inc. DCTH priced its public offering of 13.3 million shares and additional warrants at a 37% discount to its Thursday closing price. Shares dropped 36% in …

    Delcath Systems Announces New Drug Application …

      https://www.prnewswire.com/news-releases/delcath-systems-announces-new-drug-application-resubmission-for-hepzato-kit-301746377.html
      NEW YORK, Feb. 14, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of …

    Found Delcath Systems Inc information?

    The links above have surely given you a comprehensive answer to all questions about Delcath Systems Inc.

    If you are interested in any other information about business companies, choose the appropriate page.

    Related Info